Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fu-Hwa Liu
MPT0B169, a New Antitubulin Agent, Inhibits BCR-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells
PLoS ONE
Multidisciplinary
Related publications
Anti-Rheumatic Agent Auranofin Induced Apoptosis in Chronic Myeloid Leukemia Cells Resistant to Imatinib Through Both BCR/Abl-Dependent and -Independent Mechanisms
Oncotarget
Oncology
Arginine Butyrate Downregulates P210 BCR-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
NPB001-05 Inhibits BCR-Abl Kinase Leading to Apoptosis of Imatinib-Resistant Cells
Frontiers in Bioscience - Elite
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Asparaginase Induces Apoptosis and Cytoprotective Autophagy in Chronic Myeloid Leukemia Cells
Oncotarget
Oncology
Differential Genomics and Transcriptomics Between Tyrosine Kinase Inhibitor-Sensitive and -Resistant BCR-ABL-dependent Chronic Myeloid Leukemia
Oncotarget
Oncology
Gene Expression Signature of Primary Imatinib-Resistant Chronic Myeloid Leukemia Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Nilotinib Significantly Induces Apoptosis in Imatinib Resistant K562 Cells With Wild-Type BCR–ABL, as Effectively as in Parental Sensitive Counterparts
Hematology
Hematology
Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
